{"entity":{"type":"insider","cik":"0001607965","url":"/insider/0001607965","json_url":"/insider/0001607965.json","name":"Hindman Andrew A.","name_source":"as-filed","also_issuer":false,"cross_url":null},"coverage_statement":{"n_transactions":10,"n_filings":9,"first":"2015-05-15","last":"2022-11-22","span_basis":"filed_date"},"name_variants":[{"name":"Hindman Andrew A.","source":"filing","n_filings":9,"first_seen":"2015-05-15","last_seen":"2022-11-22"}],"transactions":[{"id":6410141,"accession":"0001415889-22-011671","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001415889-22-011671","line_url":"/filing/0001415889-22-011671#line-1","is_derivative":false,"issuer_cik":"0001583107","issuer_name":"Theravance Biopharma, Inc.","issuer_ticker":"TBPH","issuer_name_source":null,"issuer_url":"/issuer/0001583107","owner_cik":"0001607965","owner_name":"Hindman Andrew A.","owner_display_name":"Hindman Andrew A.","owner_url":"/insider/0001607965","role":"Officer (SVP, CHIEF FINANCIAL OFFICER)","role_mark":"O","role_mark_label":"Officer (SVP, CHIEF FINANCIAL OFFICER)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"SVP, CHIEF FINANCIAL OFFICER","security_title":"Ordinary Shares","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":65000.0,"shares_display":"65,000","price_per_share":11.0191,"price_display":"11.02","price_state":"stated","total_value":716241.5,"total_display":"716,241.50","total_whole":"716,242","shares_owned_after":409771.0,"shares_owned_after_display":"409,771","ownership_form":"D","is_10b5_1":null,"transaction_date":"2022-11-18","filed_date":"2022-11-22","scope":"insider"},{"id":6830941,"accession":"0001209191-18-061104","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001209191-18-061104","line_url":"/filing/0001209191-18-061104#line-1","is_derivative":false,"issuer_cik":"0001008848","issuer_name":"ACORDA THERAPEUTICS INC","issuer_ticker":"ACOR","issuer_name_source":null,"issuer_url":"/issuer/0001008848","owner_cik":"0001607965","owner_name":"Hindman Andrew A.","owner_display_name":"Hindman Andrew A.","owner_url":"/insider/0001607965","role":"Officer (Chief Business Officer)","role_mark":"O","role_mark_label":"Officer (Chief Business Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Business Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":753.0,"shares_display":"753","price_per_share":20.5556,"price_display":"20.56","price_state":"stated","total_value":15478.3668,"total_display":"15,478.37","total_whole":"15,478","shares_owned_after":5171.0,"shares_owned_after_display":"5,171","ownership_form":"D","is_10b5_1":null,"transaction_date":"2018-12-03","filed_date":"2018-12-06","scope":"insider"},{"id":6100959,"accession":"0001209191-18-034062","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001209191-18-034062","line_url":"/filing/0001209191-18-034062#line-1","is_derivative":false,"issuer_cik":"0001008848","issuer_name":"ACORDA THERAPEUTICS INC","issuer_ticker":"ACOR","issuer_name_source":null,"issuer_url":"/issuer/0001008848","owner_cik":"0001607965","owner_name":"Hindman Andrew A.","owner_display_name":"Hindman Andrew A.","owner_url":"/insider/0001607965","role":"Officer (Chief Business Officer)","role_mark":"O","role_mark_label":"Officer (Chief Business Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Business Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":42615.0,"shares_display":"42,615","price_per_share":24.2639,"price_display":"24.26","price_state":"stated","total_value":1034006.0985,"total_display":"1,034,006.10","total_whole":"1,034,006","shares_owned_after":4503.0,"shares_owned_after_display":"4,503","ownership_form":"D","is_10b5_1":null,"transaction_date":"2018-05-25","filed_date":"2018-05-30","scope":"insider"},{"id":5183034,"accession":"0001209191-17-063696","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001209191-17-063696","line_url":"/filing/0001209191-17-063696#line-1","is_derivative":false,"issuer_cik":"0001008848","issuer_name":"ACORDA THERAPEUTICS INC","issuer_ticker":"ACOR","issuer_name_source":null,"issuer_url":"/issuer/0001008848","owner_cik":"0001607965","owner_name":"Hindman Andrew A.","owner_display_name":"Hindman Andrew A.","owner_url":"/insider/0001607965","role":"Officer (Chief Business Dev. Officer)","role_mark":"O","role_mark_label":"Officer (Chief Business Dev. Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Business Dev. Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":817.0,"shares_display":"817","price_per_share":20.5436,"price_display":"20.54","price_state":"stated","total_value":16784.1212,"total_display":"16,784.12","total_whole":"16,784","shares_owned_after":45306.0,"shares_owned_after_display":"45,306","ownership_form":"D","is_10b5_1":null,"transaction_date":"2017-12-01","filed_date":"2017-12-05","scope":"insider"},{"id":4540908,"accession":"0001209191-17-033030","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001209191-17-033030","line_url":"/filing/0001209191-17-033030#line-1","is_derivative":false,"issuer_cik":"0001008848","issuer_name":"ACORDA THERAPEUTICS INC","issuer_ticker":"ACOR","issuer_name_source":null,"issuer_url":"/issuer/0001008848","owner_cik":"0001607965","owner_name":"Hindman Andrew A.","owner_display_name":"Hindman Andrew A.","owner_url":"/insider/0001607965","role":"Officer (Chief Business Dev. Officer)","role_mark":"O","role_mark_label":"Officer (Chief Business Dev. Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Business Dev. Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":7704.0,"shares_display":"7,704","price_per_share":15.7475,"price_display":"15.75","price_state":"stated","total_value":121318.74,"total_display":"121,318.74","total_whole":"121,319","shares_owned_after":46123.0,"shares_owned_after_display":"46,123","ownership_form":"D","is_10b5_1":null,"transaction_date":"2017-05-15","filed_date":"2017-05-17","scope":"insider"},{"id":2558876,"accession":"0001209191-16-153403","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001209191-16-153403","line_url":"/filing/0001209191-16-153403#line-1","is_derivative":false,"issuer_cik":"0001008848","issuer_name":"ACORDA THERAPEUTICS INC","issuer_ticker":"ACOR","issuer_name_source":null,"issuer_url":"/issuer/0001008848","owner_cik":"0001607965","owner_name":"Hindman Andrew A.","owner_display_name":"Hindman Andrew A.","owner_url":"/insider/0001607965","role":"Officer (Chief Business Dev. Officer)","role_mark":"O","role_mark_label":"Officer (Chief Business Dev. Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Business Dev. Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":443.0,"shares_display":"443","price_per_share":20.7225,"price_display":"20.72","price_state":"stated","total_value":9180.0675,"total_display":"9,180.07","total_whole":"9,180","shares_owned_after":49227.0,"shares_owned_after_display":"49,227","ownership_form":"D","is_10b5_1":null,"transaction_date":"2016-12-01","filed_date":"2016-12-05","scope":"insider"},{"id":2509838,"accession":"0001209191-16-120280","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001209191-16-120280","line_url":"/filing/0001209191-16-120280#line-1","is_derivative":false,"issuer_cik":"0001008848","issuer_name":"ACORDA THERAPEUTICS INC","issuer_ticker":"ACOR","issuer_name_source":null,"issuer_url":"/issuer/0001008848","owner_cik":"0001607965","owner_name":"Hindman Andrew A.","owner_display_name":"Hindman Andrew A.","owner_url":"/insider/0001607965","role":"Officer (Chief Business Dev. Officer)","role_mark":"O","role_mark_label":"Officer (Chief Business Dev. Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Business Dev. Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":4860.0,"shares_display":"4,860","price_per_share":26.108,"price_display":"26.11","price_state":"stated","total_value":126884.88,"total_display":"126,884.88","total_whole":"126,885","shares_owned_after":49670.0,"shares_owned_after_display":"49,670","ownership_form":"D","is_10b5_1":null,"transaction_date":"2016-05-13","filed_date":"2016-05-16","scope":"insider"},{"id":8868047,"accession":"0001209191-15-083226","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001209191-15-083226","line_url":"/filing/0001209191-15-083226#line-1","is_derivative":false,"issuer_cik":"0001008848","issuer_name":"ACORDA THERAPEUTICS INC","issuer_ticker":"ACOR","issuer_name_source":null,"issuer_url":"/issuer/0001008848","owner_cik":"0001607965","owner_name":"Hindman Andrew A.","owner_display_name":"Hindman Andrew A.","owner_url":"/insider/0001607965","role":"Officer (Chief Business Dev. Officer)","role_mark":"O","role_mark_label":"Officer (Chief Business Dev. Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Business Dev. Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":442.0,"shares_display":"442","price_per_share":38.26,"price_display":"38.26","price_state":"stated","total_value":16910.92,"total_display":"16,910.92","total_whole":"16,911","shares_owned_after":54530.0,"shares_owned_after_display":"54,530","ownership_form":"D","is_10b5_1":null,"transaction_date":"2015-12-01","filed_date":"2015-12-03","scope":"insider"},{"id":8340396,"accession":"0001209191-15-043432","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001209191-15-043432","line_url":"/filing/0001209191-15-043432#line-2","is_derivative":false,"issuer_cik":"0001008848","issuer_name":"ACORDA THERAPEUTICS INC","issuer_ticker":"ACOR","issuer_name_source":null,"issuer_url":"/issuer/0001008848","owner_cik":"0001607965","owner_name":"Hindman Andrew A.","owner_display_name":"Hindman Andrew A.","owner_url":"/insider/0001607965","role":"Officer (Chief Business Dev. Officer)","role_mark":"O","role_mark_label":"Officer (Chief Business Dev. Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Business Dev. Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":475.0,"shares_display":"475","price_per_share":30.16,"price_display":"30.16","price_state":"stated","total_value":14326.0,"total_display":"14,326.00","total_whole":"14,326","shares_owned_after":54972.0,"shares_owned_after_display":"54,972","ownership_form":"D","is_10b5_1":null,"transaction_date":"2015-05-15","filed_date":"2015-05-15","scope":"insider"},{"id":8340392,"accession":"0001209191-15-043432","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001209191-15-043432","line_url":"/filing/0001209191-15-043432#line-1","is_derivative":false,"issuer_cik":"0001008848","issuer_name":"ACORDA THERAPEUTICS INC","issuer_ticker":"ACOR","issuer_name_source":null,"issuer_url":"/issuer/0001008848","owner_cik":"0001607965","owner_name":"Hindman Andrew A.","owner_display_name":"Hindman Andrew A.","owner_url":"/insider/0001607965","role":"Officer (Chief Business Dev. Officer)","role_mark":"O","role_mark_label":"Officer (Chief Business Dev. Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Business Dev. Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":4304.0,"shares_display":"4,304","price_per_share":29.7787,"price_display":"29.78","price_state":"stated","total_value":128167.5248,"total_display":"128,167.52","total_whole":"128,168","shares_owned_after":55447.0,"shares_owned_after_display":"55,447","ownership_form":"D","is_10b5_1":null,"transaction_date":"2015-05-13","filed_date":"2015-05-15","scope":"insider"}],"collapsed":true,"next_cursor":null,"ledger_fault":false,"count":{"value":10,"kind":"exact"},"open_market_only":false,"composition":{"kind":"exact","rows":[{"code":"P","label":"Open-market purchase","n":0,"open_market":true},{"code":"S","label":"Open-market sale","n":10,"open_market":true},{"code":"M","label":"Option exercise","n":0,"open_market":false},{"code":"A","label":"Grant or award","n":0,"open_market":false},{"code":"F","label":"Tax withholding","n":0,"open_market":false},{"code":"D","label":"Disposition to the issuer","n":0,"open_market":false},{"code":"X","label":"In-the-money option exercise","n":0,"open_market":false}],"total":10},"affiliations":[{"type":"issuer","type_label":"ISSUER","cik":"0001583107","name":"Theravance Biopharma, Inc.","url":"/issuer/0001583107","role":"Officer (SVP, CHIEF FINANCIAL OFFICER)","n_filings":1,"first_seen":"2022-11-22","last_seen":"2022-11-22"},{"type":"issuer","type_label":"ISSUER","cik":"0001008848","name":"ACORDA THERAPEUTICS INC","url":"/issuer/0001008848","role":"Officer (Chief Business Officer)","n_filings":8,"first_seen":"2015-05-15","last_seen":"2018-12-06"}],"order_statement":"Newest transaction date first, id breaking the tie.","canonical_url":"https://ebomi.com/insider/0001607965","retrieved_at":"2026-08-23T22:29:52+00:00","coverage":{"filings":1506293,"transactions":4290787,"issuers":28597,"insiders":152303,"first_filed_date":"2003-06-30","last_filed_date":"2026-08-21","last_ingest":"2026-08-22T05:23:40.159918+00:00","counts_are":{"filings":"estimate","transactions":"estimate","issuers":"estimate","insiders":"estimate"},"source":"SEC EDGAR Form 4 filings, parsed by ebomi","fault":false},"license":{"underlying_records":"US SEC filings are public records of the United States government and are not subject to copyright. The transactional facts in them are not ours to license.","this_presentation":"The parsing, normalisation, curation, and presentation are ebomi's own work.","grant":"undecided","grant_note":"The open licence for ebomi's own layer is an open owner decision (SPEC-20260731T1159Z open question 3: CC BY 4.0 or CC0 with a citation request). Until it is taken, no grant is asserted here.","citation_request":"Balogh, A. Insider trading. Scientific Data 10, 237 (2023)","url":"https://ebomi.com/license"},"fair_use":{"policy":"These JSON endpoints are open and unauthenticated. Please read them at a human pace, identify your client in the User-Agent header, and use the published dataset for bulk work rather than crawling page by page.","bulk_alternative":"doi:10.1038/s41597-023-02147-6"}}